Skip to content
CRI Logo
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Types
    • Cancer Types
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Clinical Accelerator
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Ways to Give
    • Fundraise
    • Events
    • Partnership
    • Contact
Donate

Immune to Cancer: The CRI Blog

  • Markiplier Bares All for Cancer Research

    YouTube celebrity Markiplier created and sold a humorous calendar, donating the proceeds to the Cancer Research Institute.

    January 31, 2019| Brian Brewer
  • Curtis Garbett

    Curtis Garbett’s Immunotherapy Story

    Bladder Cancer |  Diagnosed 2015 Advancing cancer research and visioning a future immune to bladder cancer Curtis’s Story…
    January 16, 2019| CRI Staff
  • Cancer Immunotherapy: The Year in Review and a Look at the Year Ahead

    Dr. Elizabeth Jaffee highlights 2018’s advances and 2019’s potential breakthroughs in cancer treatment

    January 16, 2019| Arthur N. Brodsky, PhD
  • Learning from a Courageous Dog with Cancer

    Francesca Pearson organized a Facebook fundraiser in memory of her dog Bosch. 

    January 3, 2019| Chary Sathea
  • How Immunotherapy Is Making an Impact in Liver Cancer

    We spoke with Bruno Sangro, MD, PhD, about the current treatment landscape for patients with liver cancer,…

    December 21, 2018| Arthur N. Brodsky, PhD
  • Six CRI-Funded Scientists on Dr. James P. Allison’s Impact on Their Lives and Careers

    We spoke with six CRI-funded scientists who have worked in Allison’s lab about their experiences and the impact…

    December 6, 2018| Arthur N. Brodsky, PhD
  • Dave White

    David’s Immunotherapy Story

    Melanoma |  Diagnosed 2014 I am not a statistic. David’s Story Melanoma, that word had always been terrifying…
    December 1, 2018| CRI Staff
  • ASH18 Preview: Blood Cancer Immunotherapy Developments at 60th American Society of Hematology Meeting

    The 2018 American Society of Hematology meeting will showcase a variety of basic and clinical advances in…

    November 30, 2018| Arthur N. Brodsky, PhD
  • FDA Approves Pembrolizumab Immunotherapy for Advanced Liver Cancer

    Patients with advanced hepatocellular carcinoma (HCC), the most common form of liver cancer, can now receive PD-1…

    November 9, 2018| Arthur N. Brodsky, PhD
Previous Page
1 … 55 56 57 58 59 … 99
Next Page
Father and son

Join CRI in Shaping the Future of Immunotherapy

Support the pioneering work of CRI in advancing immunotherapy.

See ways to give

Uniting for a World
Immune to Cancer

Stay Up To Date

Get Patient Stories & Research Updates


Donate By Mail

Cancer Research Institute
29 Broadway, Floor 4
New York, NY 10006-3111

Quick Links

  • Our Annual Impact
  • Blog
  • Careers
  • Contact Us
  • Donate

Trusted & Top-Rated charity

Charity Navigator
Candid Platinum Transparency 2026
Charity Watch Top Rated
BBB Accredited Business

connect with Us

LinkedIn icon
Facebook Icon
X icon
Instagram icon
YouTube icon

The Cancer Research Institute is a 501(c)(3) charitable organization. Our Federal Tax ID Number is 13-1837442.

©2026 Cancer Research Institute

*Immunotherapy results may vary from patient to patient.

  • Accessibility Statement
  • Privacy Policy
  • Terms & Conditions
Trigger Donate Modal